As therapies for breast cancer continue to emerge, the issues of how to best monitor success and gauge prognosis remain important questions. At the CTRC-AACR San Antonio Breast Cancer Symposium, researchers presented new data on Herceptin, circulating tumor cells, mucinous breast carcinoma and the role of the Ki67 antigen during a press conference on Saturday, Dec. 12, 2009, at 8:00 a.m. CT. Listen to a recording of the teleconference below and read the release to learn more.
* the mp3 of the teleconference (11.2 MB, 49 minutes and 10 seconds)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.